Vascular Response to Isoproterenol and β2 Adrenergic Receptor Polymorphisms
NCT00226551
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Coronary Disease
Interventions
DRUG:
Isoproterenol
Sponsor
Hadassah Medical Organization